2023 Q2 Form 10-Q Financial Statement

#000173112223001128 Filed on June 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $3.020M $3.060M
YoY Change -1.3% -83.14%
Cost Of Revenue $3.146M $2.672M
YoY Change 17.71% -77.47%
Gross Profit -$125.4K $387.7K
YoY Change -132.34% -93.83%
Gross Profit Margin -4.15% 12.67%
Selling, General & Admin $3.837M $5.406M
YoY Change -29.02% -47.82%
% of Gross Profit 1394.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $170.00
YoY Change
% of Gross Profit
Operating Expenses $3.837M $5.406M
YoY Change -29.02% -47.82%
Operating Profit -$3.962M -$5.018M
YoY Change -21.04% 23.22%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.962M -$5.018M
YoY Change -21.04% 23.23%
Income Tax -$5.810K
% Of Pretax Income
Net Earnings -$3.962M -$5.012M
YoY Change -20.95% 17.69%
Net Earnings / Revenue -131.18% -163.8%
Basic Earnings Per Share -$1.48
Diluted Earnings Per Share -$0.07 -$163.3K
COMMON SHARES
Basic Shares Outstanding 58.17M shares
Diluted Shares Outstanding 2.675M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.124M $4.662M
YoY Change -75.88% 117.76%
Cash & Equivalents $1.124M $4.727M
Short-Term Investments
Other Short-Term Assets $181.9K $441.4K
YoY Change -58.79% 1371.43%
Inventory $3.647M $9.214M
Prepaid Expenses $181.9K
Receivables $1.534M $1.176M
Other Receivables $1.448M $1.754M
Total Short-Term Assets $7.936M $17.25M
YoY Change -53.99% -64.88%
LONG-TERM ASSETS
Property, Plant & Equipment $1.108M $48.30K
YoY Change 2193.6% -23.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.190K
YoY Change
Total Long-Term Assets $2.879M $48.29K
YoY Change 5862.07% -23.2%
TOTAL ASSETS
Total Short-Term Assets $7.936M $17.25M
Total Long-Term Assets $2.879M $48.29K
Total Assets $10.81M $17.29M
YoY Change -37.47% -64.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $163.3K $3.620M
YoY Change -95.49% -90.54%
Accrued Expenses $696.9K $480.8K
YoY Change 44.95% -70.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.221M $4.103M
YoY Change 2.88% -89.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $961.6K $39.18K
YoY Change 2354.29% -25.88%
Total Long-Term Liabilities $961.6K $39.18K
YoY Change 2354.29% -25.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.221M $4.103M
Total Long-Term Liabilities $961.6K $39.18K
Total Liabilities $5.182M $4.142M
YoY Change 25.12% -89.63%
SHAREHOLDERS EQUITY
Retained Earnings -$26.59M
YoY Change
Common Stock $56.17K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.632M $13.15M
YoY Change
Total Liabilities & Shareholders Equity $10.81M $17.29M
YoY Change -37.47% -64.82%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$3.962M -$5.012M
YoY Change -20.95% 17.69%
Depreciation, Depletion And Amortization $170.00
YoY Change
Cash From Operating Activities -$2.649M -$2.471M
YoY Change 7.21% -1188.86%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.542M
YoY Change -100.0% -3314.11%
NET CHANGE
Cash From Operating Activities -2.649M -2.471M
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000 1.542M
Net Change In Cash -2.649M -928.9K
YoY Change 185.19% -619.07%
FREE CASH FLOW
Cash From Operating Activities -$2.649M -$2.471M
Capital Expenditures $0.00
Free Cash Flow -$2.649M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Depreciation
Depreciation
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001762239
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
usd
CY2022Q4 kavl Due To Other Related Party Classified Current
DueToOtherRelatedPartyClassifiedCurrent
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 kavl Royalty Revenue
RoyaltyRevenue
usd
CY2022Q2 kavl Royalty Revenue
RoyaltyRevenue
usd
kavl Royalty Revenue
RoyaltyRevenue
usd
CY2023Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
usd
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
usd
us-gaap Investment Income Net
InvestmentIncomeNet
usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
kavl Increase Decrease In Inventory Deposit Related Party
IncreaseDecreaseInInventoryDepositRelatedParty
usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
kavl Settled Rsus With Cash
SettledRsusWithCash
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56016
dei Entity Registrant Name
EntityRegistrantName
KAIVAL BRANDS INNOVATIONS GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-3492907
dei Entity Address Address Line1
EntityAddressAddressLine1
4460 Old Dixie Highway
dei Entity Address City Or Town
EntityAddressCityOrTown
Grant-Valkaria
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32949
dei City Area Code
CityAreaCode
(833)
dei Local Phone Number
LocalPhoneNumber
452-4825
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
KAVL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58169090 shares
CY2023Q2 us-gaap Cash
Cash
1124371 usd
CY2022Q4 us-gaap Cash
Cash
3685893 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1534236 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
574606 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1448376 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1539486 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
3646738 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1239725 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
181921 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
426407 usd
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
1607302 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
7935642 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
9073419 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3190 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
1771270 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
2164646 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1104622 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1198969 usd
CY2023Q2 us-gaap Assets
Assets
10814724 usd
CY2022Q4 us-gaap Assets
Assets
12437034 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
163270 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
40023 usd
CY2023Q2 kavl Due To Other Related Party Classified Current
DueToOtherRelatedPartyClassifiedCurrent
2122452 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
696876 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1099157 usd
CY2023Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
12099 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
44973 usd
CY2023Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
921078 usd
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
0 usd
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
129702 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
235274 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175206 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
166051 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4220683 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1585478 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
961593 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1050776 usd
CY2023Q2 us-gaap Liabilities
Liabilities
5182276 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2636254 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56169090 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56169090 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56169090 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56169090 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
56169 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
56169 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32164512 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29375787 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26588233 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19631176 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
5632448 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9800780 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10814724 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12437034 usd
CY2023Q2 kavl Revenue
Revenue
3046657 usd
CY2022Q2 kavl Revenue
Revenue
3092366 usd
kavl Revenue
Revenue
5482492 usd
kavl Revenue
Revenue
5934356 usd
CY2023Q2 kavl Revenue From Related Party
RevenueFromRelatedParty
3628 usd
CY2022Q2 kavl Revenue From Related Party
RevenueFromRelatedParty
7385 usd
kavl Revenue From Related Party
RevenueFromRelatedParty
6713 usd
kavl Revenue From Related Party
RevenueFromRelatedParty
31150 usd
kavl Royalty Revenue
RoyaltyRevenue
105572 usd
CY2023Q2 kavl Excise Tax On Products
ExciseTaxOnProducts
29983 usd
CY2022Q2 kavl Excise Tax On Products
ExciseTaxOnProducts
39727 usd
kavl Excise Tax On Products
ExciseTaxOnProducts
48557 usd
kavl Excise Tax On Products
ExciseTaxOnProducts
63599 usd
CY2023Q2 us-gaap Revenues
Revenues
3020302 usd
CY2022Q2 us-gaap Revenues
Revenues
3060024 usd
us-gaap Revenues
Revenues
5546220 usd
us-gaap Revenues
Revenues
5901907 usd
CY2023Q2 kavl Cost Of Revenue Related Party
CostOfRevenueRelatedParty
3145652 usd
CY2022Q2 kavl Cost Of Revenue Related Party
CostOfRevenueRelatedParty
2627430 usd
kavl Cost Of Revenue Related Party
CostOfRevenueRelatedParty
5131452 usd
kavl Cost Of Revenue Related Party
CostOfRevenueRelatedParty
6112050 usd
CY2022Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
44925 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
93097 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
3145652 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
2672355 usd
us-gaap Cost Of Revenue
CostOfRevenue
5131452 usd
us-gaap Cost Of Revenue
CostOfRevenue
6205147 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-125350 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
387669 usd
us-gaap Gross Profit
GrossProfit
414768 usd
us-gaap Gross Profit
GrossProfit
-303240 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
660132 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
761069 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1249042 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1353570 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3176666 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4644567 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6134735 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6143121 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3836798 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
5405636 usd
us-gaap Operating Expenses
OperatingExpenses
7383777 usd
us-gaap Operating Expenses
OperatingExpenses
7496691 usd
us-gaap Investment Income Net
InvestmentIncomeNet
11952 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11952 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3962148 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5017967 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6957057 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7799931 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5807 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5807 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3962148 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5012160 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6957057 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7794124 usd
CY2023Q2 kavl Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.07
CY2022Q2 kavl Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.16
kavl Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.12
kavl Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.25
CY2023Q2 kavl Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
56169090 shares
CY2022Q2 kavl Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
30701393 shares
kavl Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
56169090 shares
kavl Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
30680701 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9800780 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
1435787 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2994909 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8241658 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
1352938 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3962148 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
5632448 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16324313 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
110250 usd
CY2022Q1 kavl Common Shares Settled And Cancelled
CommonSharesSettledAndCancelled
-35759 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
309700 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2781964 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
13926540 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
80166 usd
CY2022Q2 kavl Common Shares Settled And Cancelled
CommonSharesSettledAndCancelled
-24058 usd
CY2022Q2 kavl Exercise Of Common Stock Warrants
ExerciseOfCommonStockWarrants
1566190 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
2616192 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-5012160 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13152870 usd
us-gaap Net Income Loss
NetIncomeLoss
-6957057 usd
us-gaap Net Income Loss
NetIncomeLoss
-7794124 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
190416 usd
us-gaap Depreciation
Depreciation
290 usd
kavl Stock Option Plan Expenses
StockOptionPlanExpenses
2788725 usd
kavl Stock Option Plan Expenses
StockOptionPlanExpenses
2925892 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4622 usd
kavl Rou Operating Lease Expense
RouOperatingLeaseExpense
94347 usd
kavl Rou Operating Lease Expense
RouOperatingLeaseExpense
7305 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
105057 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
964252 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-809603 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-484486 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-244486 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
56360 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2512070 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6112050 usd
kavl Increase Decrease In Inventory Deposit Related Party
IncreaseDecreaseInInventoryDepositRelatedParty
2925000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1607302 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
123247 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18055 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
2122452 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-9273010 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-402281 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-112525 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-105572 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-32874 usd
kavl Increase Decrease In Customer Refund Due
IncreaseDecreaseInCustomerRefundDue
-921078 usd
kavl Increase Decrease In Customer Refund Due
IncreaseDecreaseInCustomerRefundDue
314418 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-80028 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6345 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2558042 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4604571 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3480 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3480 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1566190 usd
kavl Settled Rsus With Cash
SettledRsusWithCash
59817 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1506373 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2561522 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3098198 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3685893 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7825235 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1124371 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4727037 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zkv2SKVftRr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86E_zlsCz19YxpWk">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
804971 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2912793 usd
us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
-94347 usd
us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
-7305 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1104622 usd
CY2023Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
12099 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
44973 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
129702 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
235274 usd
CY2023Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
921078 usd
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
0 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1198969 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175206 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
166051 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
961593 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1050776 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1136799 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1216827 usd
CY2023Q2 kavl Working Capital
WorkingCapital
3714959 usd
CY2021Q4 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
the Company entered into a month-to-month lease agreement with Ranger Enterprises, LLC, located in Seymour, Indiana, to store product inventory at this satellite location. The Company made payments on this lease in the amount of $19,959. The lease was terminated in June 2022.
CY2021Q4 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
the Company entered into a month-to-month lease agreement with FFE Solutions Group, located in Salt Lake City Utah, to store additional product inventory at this satellite location. The Company made payments on this lease in the amount of $19,108. This lease was terminated in April 2022.
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.045 pure
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
110809 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
228134 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
238800 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
253614 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
450934 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1282291 usd
CY2023Q2 kavl Lessee Operatings Lease Liability Undiscounted Excess Amount
LesseeOperatingsLeaseLiabilityUndiscountedExcessAmount
145492 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1136799 usd
CY2023Q1 kavl Common Stock Share Issued
CommonStockShareIssued
0 shares
kavl Common Stock Share Issued
CommonStockShareIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
kavl Reverse Stock Split Description
ReverseStockSplitDescription
as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock.
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
kavl Unrecognized Expenses Related To Options
UnrecognizedExpensesRelatedToOptions
3643178 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y4M28D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
kavl Inventory Quality Control Expenses
InventoryQualityControlExpenses
6355234 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
202461 usd
kavl Service Agreement Description
ServiceAgreementDescription
(i) payment of $125,000 per month; (ii) bonus equivalent to 0.27% of the applicable gross quarterly sales and (iii) a grant of 3,000,000 nonqualified stock options to purchase shares of Company common stock which shall vest based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years.
CY2023Q2 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
35338 usd
CY2022Q2 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
33871 usd
CY2023Q1 kavl Brokerage Commission
BrokerageCommission
0.05 pure

Files In Submission

Name View Source Status
0001731122-23-001128-index-headers.html Edgar Link pending
0001731122-23-001128-index.html Edgar Link pending
0001731122-23-001128.txt Edgar Link pending
0001731122-23-001128-xbrl.zip Edgar Link pending
e4787_10q.htm Edgar Link pending
e4787_ex10-1.htm Edgar Link pending
e4787_ex3-1.htm Edgar Link pending
e4787_ex31-1.htm Edgar Link pending
e4787_ex31-2.htm Edgar Link pending
e4787_ex32-1.htm Edgar Link pending
e4787_ex32-2.htm Edgar Link pending
e4787_ex4-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kavl-20230430.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
kavl-20230430_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
kavl-20230430_pre.xml Edgar Link unprocessable
e4787_10q_htm.xml Edgar Link completed
kavl-20230430_lab.xml Edgar Link unprocessable
kavl-20230430_cal.xml Edgar Link unprocessable